• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • About Us
  • Blog
  • Subscribe to the Journal
  • Contact Us
Sleep Diagnosis and Therapy

Sleep Diagnosis and Therapy

Official Publication of the American Sleep and Breathing Academy

FMI Predicts Sleep Aids Likely to Boost Narcolepsy Market

February 5, 2021 by admin

Officials at Future Market Insights (FMI) predict the worldwide market for narcolepsy treatment is anticipated to account for $3.8 billion in revenue over the next decade. FMI attributes significant demand for narcolepsy treatment in North America and Europe, particularly given the increasing affinity toward prescription treatments on a long haul basis. FMI concludes that there is a cognizant transfer from OTC medication to devices handling narcolepsy, fueling revenue expansion for the devices category in contrast to drugs.

Key Takeaways from Narcolepsy Treatment Market Study

  • Foremost narcolepsy treatment makers are prioritizing area-specific product expansion. The product portfolio growth is majorly targeted in the APAC region.
  • Apart from novel product expansion—majorly increasing from the existence of low price generic interpretations of patented drugs, strategic acquisitions, and partnerships will pave way for additional business growths.
  • Makers in the worldwide narcolepsy treatment market are additionally concentrated toward presenting novel R&D units in several geographic regions.
  • Industry leaders are centering on keeping up long-term partnerships with pharmacies—in retail and hospital, e-commerce, and drug stores. Sales via e-commerce distribution channels are likely to add a remarkable revenue share in the worldwide narcolepsy treatment market.
  • FMI has additionally noted a rising center on the preparation of well-known combinations and products, by makers in North America to accomplish wide penetration and higher sales.

Devices in portable, in addition to available-for-rent formats, would translate into high implementation rates, all over the assessment period. Portable CPAP devices are smaller and lighter and could also be utilized as a home-based unit, bringing down the reliance on prescription drugs and OTC pills.

 

Filed Under: Blog Tagged With: narcolepsy

Primary Sidebar

More to See

Snoring, American Sleep and Breathing Academy and the NY Times

August 23, 2022 By admin

Jazz Pharma Presents 17 New Posters for SLEEP 2022

June 6, 2022 By admin

Tags

apnea CPAP Health Home Sleep Home Sleep Testing insomnia narcolepsy obstructive sleep apnea Sleep sleep apnea sleep apnea symptoms sleep apnea syndrome sleep apnea treatment sleep appliances sleep buisness Sleep Business sleep center Sleep Centers sleep community sleep diagnosis sleep diagnostic sleep diagnostics sleep disease sleep disorder sleep disorder center sleep disordered breathing sleep disorders sleep heart health sleep industry sleeping Sleep Lab sleep labs sleep management sleep medicine sleep monitor sleep physicians sleep problems sleep studies sleep study sleep technologist sleep test sleep testing Technology therapy Treatment

Footer

About SleepDT

SleepDT Sleep Diagnosis and Therapy is a clinical Journal for allied Sleep Professionals, Neurologists, Psychiatrists, Pulmonologists, Primary Care Physicians, and other medical specialists. We also advocate on behalf of patient care in the field of Sleep Medicine

Recent

  • SUPPORT AND PROMOTE DENTAL SLEEP MEDICINE IN 2023!
  • Snoring, American Sleep and Breathing Academy and the NY Times
  • Jazz Pharma Presents 17 New Posters for SLEEP 2022
  • AJMC Hypes SLEEP 2022
  • Avadel Pharmaceuticals’ Stock Falls

NAVIGATION

  • Home
  • About Us
  • Blog
  • Subscribe to the Journal
  • Contact Us

Copyright © 2023 · Sleep Diagnosis and Therapy